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Purpose: Urinary pH is an important factor linked to renal stone disease and a useful marker in the treatment of
urolithiasis. Although the gold standard for measuring urinary pH utilizes a glass electrode and a pH meter, at
present dipstick testing is largely used to estimate urinary pH. However, the accuracy and precision of this method
may be insufficient for making clinical decisions in patients with lithiasis. The aim of this study is to describe a new
device for urinary pH testing.
Methods: The device includes a pH sensor based on differential measurement of an ISFET-REFET pair. The drawbacks
associated with this type of configuration, namely short lifetime and manual fabrication, have been overcome in
the prototype. An automatic one point calibration is performed when turning on the system. Two buffer solutions
were utilized to determine the intra- and inter-day precision of the device. The pH of 30 fresh human urine
samples was measured using a pH-meter, a dipstick and the new electronic device.
Results: In some cases, dipstick measurements differed from those of the pH meter by more than 0.40 units, a
clinically relevant discrepancy, whereas none of the measurements made with the new electronic device differed
from the results of the pH-meter by more than 0.1 pH units.
Conclusions: This new electronic device has the possibility to be used by stone-formers to control their urinary
pH at home, increasing the tools available for stone prevention and prophylaxis.
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Urinary pH is an important factor linked to renal stone
disease (Hess 2006). Although the formation of calcium
oxalate crystals (either mono- or dihydrate) is apparently
unrelated to urinary pH, because the solubilities of these
salts are practically unaltered at urinary pH values, a
urinary pH <5.5 may induce the formation of uric acid
crystals whereas a urinary pH >6.2 may induce the forma-
tion of calcium phosphate crystals.
The formation of calcium oxalate crystals in urine
takes place through heterogeneous nucleation processes
(Grases et al. 2012; Finlayson 1978). For this reason, the
presence of solid preformed particles is an indispensable* Correspondence: fgrases@uib.es
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ate stones.
Calcium oxalate monohydrate (COM) papillary calculi
initiate their formation in injured papillary tissue, mainly
through calcification of this tissue by hydroxyapatite.
When these deposits grow and erode the epithelium
covering the papillae, they come into contact with urine.
Due to the permanent supersaturation of calcium oxalate
in urine, and through heterogeneous nucleation, COM
papillary calculi start to develop (Grases et al. 2013).
For this reason, COM papillary calculi are unique
among renal calculi, since their formation is independent
of urinary pH (Grases et al. 2012). For the remainder
calcium oxalate stones, the presence of an adequate
number of solid preformed microparticles in urine is an
indispensable condition for their formation.
At urinary pH < 5.5, uric acid becomes insoluble and
forms crystals of anhydrous or dihydrate uric acid (Grasesn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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uric acid or mixed uric acid/COM stones will form. As ex-
pected, these types of stones were more prevalent in pa-
tients with urinary pH < 5.5 than in those with higher
urinary pH (Liebman et al. 2007). If the amount of formed
uric acid crystals is small, it can be eliminated as asymp-
tomatic crystalluria. However, due to the ability of anhyd-
rous uric acid crystals to act as heterogeneous nucleant of
COM, the development of these types of calculi may be fa-
vored under appropriate conditions of calcium oxalate
supersaturation and a deficiency of crystallization inhibi-
tors (Grases et al. 2002, 2007). The capacity of uric acid to
serve as heterogeneous nucleant of COM crystals is super-
ior to that of mucin (a glycoprotein) or cellular detritus,
but inferior to that of some calcium salts (Grases et al.
2007). Moreover, uric acid was detected as a minor com-
ponent in the core of unattached COM renal calculi, indi-
cating that the core was principally formed by COM
crystals, uric acid and organic matter (Grases et al. 2006).
In such calculi, uric acid probably played an important
role as an heterogeneous nucleant of COM crystals. Thus,
uric acid was responsible for calculus formation. Hence, it
is not surprising that a majority of COM unattached renal
stones (50,9%) developed in patients with urinary pH < 5.5
(Grases et al. 2012).
At urinary pH > 6.2, calcium phosphates (hydroxyapatite
and brushite) form insoluble salts (Söhnel & Grases 2011).
If large amounts are present, hydroxyapatite or brushite
stones will develop (Grases et al. 2012). If smaller amounts
of these crystals are present, they cannot form these
types of stones. However, due to their capacity to induce
calcium oxalate dihydrate heterogeneous nucleation
(Wu et al. 1999), they may favor the formation ofFigure 1 Images of the device (left), and pH sensor probe (right).corresponding calculi. In fact, it was found that calcium
oxalate dihydrate calculi (41,5%) were mainly present in
patients with urinary pH > 6.0 (Grases et al. 2012).
All the commented aspects demonstrate the importance
of precise urinary pH measurements. Due to its accuracy
and precision, the gold standard for pH measurements
utilizes a glass pH electrode and a pH meter. At present,
however, dipstick testing is largely used to estimate urinary
pH. Use of a pH meter is more cumbersome, due to the
requirement for regular calibration and the need for user
training. In contrast, dipsticks are cheaper and do not re-
quire user training or calibration with test solutions. Thus,
patients can use dipsticks to measure their own urinary
pH at home, avoiding the drawbacks caused by not testing
freshly voided samples. However, accuracy and precision
of dipstick pH measurements are insufficient for making
clinical decisions on patients with lithiasis (Kwong et al.
2013; Desai and Assimos 2008).
This paper describes a new, easy to use device for meas-
uring urinary pH, suitable for use by lithiasic patients at
home. This new device is based on a silicon sensor (Ion
Selective Field Effect Transistor, ISFET), with several ad-
vantages compared with the combination of a pH meter
and glass electrode: 1) greater mechanical robustness;
2) no need for maintenance; and 3) fabrication and
packaging with Integrated Circuit technologies, enab-
ling mass production at extremely low cost.
Materials and methods
Subjects and samples
The urine of 30 human volunteers was collected into
sterile receptacles. Each sample was immediately tested
twice by two fully trained operators using three methods:
Figure 2 Scheme of the experimental set-up.
Table 1 Mean and standard deviation of pH values of two
buffer solutions measured with the new electronic device
0.7 M acetate buffer
pH = 5.5
0.15 M phosphate buffer
pH = 6.5
Mean Standard deviation Mean Standard deviation
Intra-day
(n = 5)
5.42 0.04 6.50 0.00
Inter-day
(n = 5)
5.46 0.05 6.50 0.00
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urine dipsticks (Merck, Darmstadt, Germany) and the new
electronic device described below (Devicare, Barcelona,
Spain). Samples were tested in random order.
Each volunteer provided written informed consent,
and the study protocol was approved by the institutional
review board of the Balearic Islands Community (no. IB
2029/13 PI).
To establish the accuracy of each method, and to evalu-
ate the intra- and inter-day precision of the new device,
two buffer solutions were used (0.7 M acetate buffer,
pH 5.5; and 0.15 M phosphate buffer, pH 6.5). The pH of
each buffer was measured five times using each device on
each of two days.
Description and characteristics of the new electronic
device for urinary pH testing
The device resembles a standard urine specimen cup with
a special lid (Figure 1). This lid includes a pH sensor probe
that protrudes into the liquid contained in the cup and
electronic circuits for the sensor signal readout and pH
calculation. The scheme of the prototype is shown in
Figure 2. The external top surface of the lid includes a
pushbutton and a display with the measured pH. The de-
vice is also provided with a cup containing pH 6.00 buffer.
When the device is not being used, the lid is left screwed
onto the buffer cup. The device is activated by pushing the
button, automatically triggering a one point calibration.
The lid is removed from the calibration cup and placed
onto the specimen cup, which has been previously filled
with the sample to be tested. The button is pushed again
to measure the pH within a measure time inferior to
10 sec. The measured pH then appears on the display.
The pH sensor is based on the differential measurement
of two Ion Selective Field Effect Transistors (ISFETs), onemodified to work as a reference ISFET (REFET) (Compte
and Janata 1978). The REFET is simply an ISFET with a
micro-chamber containing buffer solution wetting its sen-
sitive gate. The micro-chamber is connected to the exter-
nal solution through a microchannel liquid junction. The
drawbacks associated with this type of configuration,
namely short lifetime and manual fabrication (Guth et al.
2009), have been overcome in the prototype described
here. By keeping the sensor in the buffer solution between
measurements, the solution in the REFET micro-chamber
is continuously changed by diffusion. The dimensions
of the microchamber and microchannel are designed to
withstand more than 24 h measurements without sig-
nificant contamination of the internal buffer solution.
In the present prototype, the REFET microchamber and
microchannel were fabricated from diacrylate bisphenol,
a photocurable polymer used for packaging, and subse-
quent bonding of a micromolded PDMS lid (Burdallo
et al. 2012).Results
The intra- and inter-day precision of the new device was
tested using two buffer solutions. The standard deviation
obtained for both showed excellent results (Table 1).
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three methods: a pH-meter, a dipstick and the new elec-
tronic device (Figure 3). The Pearson correlation coeffi-
cients for the dipstick and the new device were 0.922
and 0.993, respectively.
A regression of results obtained with the pH-meter vs
results obtained with the new device led to a linear
graph comparable to the theoretical line with slope = 1
and intercept = 0 at the 95% confidence level (slope =
0.982 ± 0.019; intercept = 0.06 ± 0.11).Figure 3 Scatter graphs showing the correlation of pH
measurements between pH meter and the dipstick (3a) and the
new device (3b) in fresh urine. The regression line is illustrated by
a solid line, while the unity line is shown in dotted.Table 2 summarizes the pH of fresh urine samples obt
ained with the dipstick and the pH meter in fresh urine.
The urinary pH measured with the dipstick was not suf-
ficiently accurate in patients diagnosed with lithiasis,
with differences between the two devices as high as 0.4
pH units. In contrast, the new electronic device was
more accurate and precise in measuring pH in fresh
urine (Table 3), with a maximum error of 0.1 pH units.
The characteristics of renal lithiasis indicate that the
maximum allowable error for urinary pH is 0.1 pH units.
None of the pH measurements made using the new elec-
tronic device differed from those made by the pH meter
by more than 0.1 pH units. However, more than 70% of
the differences between the dipstick and the pH meter
were above 0.1 pH units, and more than 40% had an
absolute difference of more than 0.2 pH units.
Discussion
The present study confirmed previous results (Kwong
et al. 2013) demonstrating that dipstick and pH meter
measurements of urinary pH differ markedly, with some
of these differences being clinically relevant. In the present
work, the pH of some urine samples differed by up to 0.40
pH units, suggesting that the dipstick method may be un-
reliable in making clinical decisions (Desai and Assimos
2008).
It is important for uric acid stone-formers and those
with calcium oxalate calculi induced by uric acid crystals
to distinguish between urinary pH above and below
pH 5.5. Moreover, non-infected calcium phosphate
stone-formers and patients with calcium oxalate stones
induced by calcium phosphate crystals must distinguish
between urinary pH above and below pH 6.2. The present
findings suggest, however, that the dipstick method may
be unable to accurately distinguish between urinary pH
above and below these cutoff points. These errors can
result in unnecessary (or excessive) urine alkalinization or
acidification during the implementation of prophylactic
treatments. In contrast, the new electronic device de-
scribed here showed good intra-day and inter-day preci-
sion and small (<0.1 pH unit) absolute differences from
a pH meter when measuring the pH of fresh urine sam-
ples. Taken together, these results demonstrate that thisTable 2 pH values measured with the dipstick and the
pH-meter in fresh urine
pH dipstick pH-meter Mean (±SD) Difference (±SD) n
5,0 5,14 ± 0.07 0,14 ± 0.07 5
5,5 5,34 ± 0.17 0,16 ± 0.17 10
6,0 5,78 ± 0.18 0,22 ± 0.18 6
6,5 6,33 ± 0.16 0,17 ± 0.16 7
7,0 0
7,5 7,44 ± 0.07 0,06 ± 0.07 2
Table 3 pH values measured with the new electronic
device and the pH-meter in fresh urine
pH interval pH-meter
Mean (±SD)
New device
Mean (±SD)
Difference
(±SD)
n
5-5.5 5,17 ± 0.08 5,20 ± 0.12 0.03 ± 0.14 10
5.5-6 5,60 ± 0.14 5,68 ± 0.14 0.08 ± 0.20 10
6-6.5 6,26 ± 0.14 6,29 ± 0.12 0.03 ± 0.18 7
6.5-7.5 7,17 ± 0.50 7,27 ± 0.49 0.10 ± 0.70 3
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urinary pH in stone-formers.
The proposed electronic device has an autocalibration
system, allowing urinary pH to be measured immediately
after pushing the on button. Moreover, the design of the
device suggests that it can be easily operated by an un-
trained user, such as a patient at home. Finally, to this de-
vice it could be easily introduced the automated storage
and processing of recorded pH values. Patients can there-
fore readily and more immediately control their urinary
pH by modifying their alkalinizing or acidifying therapy, as
well as avoiding errors resulting from urine transport and
storage.
In conclusion, this new electronic device has the possi-
bility for use by stone-formers in precise urinary pH
control at home, increasing the tools available for stone
prevention and prophylactic control.
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